This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Jia Wu in Antibody Development
Introduction
Jia Wu is an accomplished inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of isoform-selective anti-TGFβ antibodies. Her work is crucial for advancing treatments for various TGFβ-related disorders.
Latest Patents
Jia Wu holds a patent for "Isoform-selective anti-TGFβ antibodies and methods of use." This invention provides isoform-selective anti-TGFβ antibodies, including anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies. These antibodies are particularly useful for the treatment of fibrosis and other disorders related to TGFβ.
Career Highlights
Jia Wu is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative therapies. Her work at Genentech has allowed her to focus on groundbreaking research and development in the field of antibody therapies.
Collaborations
Jia Wu collaborates with notable colleagues, including Wei-Ching Liang and Joseph R Arron. These partnerships enhance her research efforts and contribute to the advancement of therapeutic solutions.
Conclusion
Jia Wu's innovative work in the development of isoform-selective anti-TGFβ antibodies represents a significant advancement in biotechnology. Her contributions are paving the way for new treatments for TGFβ-related disorders, showcasing her impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile